A. Sabljić
22 Papers
1 Citations
A. Sabljić is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 14 publications.
Chat about Author
Papers
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis.
Marko Lucijanic,Ivan Krečak,Ena Soric,A. Sabljić,Davor Galusic,Hrvoje Holik,Vlatka Periša,Martina Moric Peric,Ivan Zekanović,Rajko Kusec +9 more
TL;DR: In this paper , the authors found that post-PV SMF patients experience highest risk of arterial thrombotic events in comparison to PMF and post-ET SMF.
15
Gradual increase in red cell distribution width is similarly prognostic for in‐hospital mortality in both anemic and non‐anemic COVID‐19 patients
Marko Lucijanic,Ena Soric,Martina Sedinic Lacko,A. Sabljić,Ivan Krečak,Petra Bistrovic,A. Jordán,Šime Manola,Ozren Jakšić,Tomo Lucijanić,Lovorka Derek,Rajko Kusec +11 more
TL;DR: It is shown that negative prognosis of increasingRDW is present in both patients with and without anemia and is similar for each RDW percentage point, and association of increasing RDW with inferior survival is preserved in both patient subgroups with andWithout anemia after adjustments for clinically important parameters.
4
Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis
Marko Lucijanic,Ivan Krečak,Ena Soric,A. Sabljić,Davor Galusic,Hrvoje Holik,Vlatka Periša,Martina Morić Perić,Ivan Zekanović,Rajko Kusec +9 more
TL;DR: In this paper , the Strauss-derived Duarte formula was used to calculate the estimated plasma volume status (ePVS) in polycythemia vera patients with myelofibrosis.
4
Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre
Petra Bistrovic,A. Sabljić,Ivona Kovačević,Tomislav Čikara,T. Kereš,Tomo Lucijanić,Joško Mitrović,Diana Delić-Brkljačić,Šime Manola,Marko Lucijanic +9 more
TL;DR: In this paper , a large cohort of COVID-19 patients from a tertiary hospital were evaluated according to the prior non-OAC, warfarin and direct oral anticoagulants (DOAC) use.
3
Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
Marko Lucijanic,Ivana Jurin,Martina Sedinic,Ena Soric,A. Sabljić,Ivan Krečak,Joško Mitrović,Daniela Marelic,Zvonimir Kremer,Irzal HadžibegoviĿ,Tomo Lucijanić,Rajko Kusec +11 more
TL;DR: Lucijanic et al. as discussed by the authors evaluated predictive properties of several thrombotic risk prediction scores in a large cohort of hospitalized COVID-19 patients and concluded that the D-dimer based IMPROVEDD score was best for VTE prediction.
3